278 related articles for article (PubMed ID: 25288727)
21. Delivery of oncolytic adenovirus into the nucleus of tumorigenic cells by tumor microparticles for virotherapy.
Ran L; Tan X; Li Y; Zhang H; Ma R; Ji T; Dong W; Tong T; Liu Y; Chen D; Yin X; Liang X; Tang K; Ma J; Zhang Y; Cao X; Hu Z; Qin X; Huang B
Biomaterials; 2016 May; 89():56-66. PubMed ID: 26950165
[TBL] [Abstract][Full Text] [Related]
22. Combining NanoKnife with M1 oncolytic virus enhances anticancer activity in pancreatic cancer.
Sun S; Liu Y; He C; Hu W; Liu W; Huang X; Wu J; Xie F; Chen C; Wang J; Lin Y; Zhu W; Yan G; Cai J; Li S
Cancer Lett; 2021 Apr; 502():9-24. PubMed ID: 33444691
[TBL] [Abstract][Full Text] [Related]
23. Identification of the receptor of oncolytic virus M1 as a therapeutic predictor for multiple solid tumors.
Song D; Jia X; Liu X; Hu L; Lin K; Xiao T; Qiao Y; Zhang J; Dan J; Wong C; Hu C; Sai K; Gong S; Sander M; Shen R; Chen X; Xiao X; Chen J; Zhang Y; Wei C; Xiao X; Liang J; Zhang Q; Hu J; Zhu W; Yan G; Lin Y; Cai J
Signal Transduct Target Ther; 2022 Apr; 7(1):100. PubMed ID: 35393389
[TBL] [Abstract][Full Text] [Related]
24. Oncolytic viruses in cancer therapy.
Vähä-Koskela MJ; Heikkilä JE; Hinkkanen AE
Cancer Lett; 2007 Sep; 254(2):178-216. PubMed ID: 17383089
[TBL] [Abstract][Full Text] [Related]
25. Virus-tumor interactome screen reveals ER stress response can reprogram resistant cancers for oncolytic virus-triggered caspase-2 cell death.
Mahoney DJ; Lefebvre C; Allan K; Brun J; Sanaei CA; Baird S; Pearce N; Grönberg S; Wilson B; Prakesh M; Aman A; Isaac M; Mamai A; Uehling D; Al-Awar R; Falls T; Alain T; Stojdl DF
Cancer Cell; 2011 Oct; 20(4):443-56. PubMed ID: 22014571
[TBL] [Abstract][Full Text] [Related]
26. Functional interactions of antiapoptotic proteins and tumor necrosis factor in the context of a replication-competent adenovirus.
Liu TC; Wang Y; Hallden G; Brooks G; Francis J; Lemoine NR; Kirn D
Gene Ther; 2005 Sep; 12(17):1333-46. PubMed ID: 15920462
[TBL] [Abstract][Full Text] [Related]
27. Targeting of interferon-beta to produce a specific, multi-mechanistic oncolytic vaccinia virus.
Kirn DH; Wang Y; Le Boeuf F; Bell J; Thorne SH
PLoS Med; 2007 Dec; 4(12):e353. PubMed ID: 18162040
[TBL] [Abstract][Full Text] [Related]
28. Antitumoural immunity by virus-mediated immunogenic apoptosis inhibits metastatic growth of hepatocellular carcinoma.
Boozari B; Mundt B; Woller N; Strüver N; Gürlevik E; Schache P; Kloos A; Knocke S; Manns MP; Wirth TC; Kubicka S; Kühnel F
Gut; 2010 Oct; 59(10):1416-26. PubMed ID: 20675696
[TBL] [Abstract][Full Text] [Related]
29. Efficacy of oncolytic mutants targeting pRb and p53 pathways is synergistically enhanced when combined with cytotoxic drugs in prostate cancer cells and tumor xenografts.
Radhakrishnan S; Miranda E; Ekblad M; Holford A; Pizarro MT; Lemoine NR; Halldén G
Hum Gene Ther; 2010 Oct; 21(10):1311-25. PubMed ID: 20497039
[TBL] [Abstract][Full Text] [Related]
30. MicroRNA-Attenuated Clone of Virulent Semliki Forest Virus Overcomes Antiviral Type I Interferon in Resistant Mouse CT-2A Glioma.
Martikainen M; Niittykoski M; von und zu Fraunberg M; Immonen A; Koponen S; van Geenen M; Vähä-Koskela M; Ylösmäki E; Jääskeläinen JE; Saksela K; Hinkkanen A
J Virol; 2015 Oct; 89(20):10637-47. PubMed ID: 26269187
[TBL] [Abstract][Full Text] [Related]
31. Oncolytic Virus Alphavirus M1: A New and Promising Weapon to Fight Cancer.
Muhuri M; Gao G
Hum Gene Ther; 2021 Feb; 32(3-4):136-137. PubMed ID: 33621140
[No Abstract] [Full Text] [Related]
32. A mathematical model of oncolytic virotherapy with time delay.
Wang ZZ; Guo ZM; Smith H
Math Biosci Eng; 2019 Mar; 16(4):1836-1860. PubMed ID: 31137188
[TBL] [Abstract][Full Text] [Related]
33. Reexpression of human somatostatin receptor gene 2 gene mediated by oncolytic adenovirus increases antitumor activity of tumor necrosis factor-related apoptosis-inducing ligand against pancreatic cancer.
Zhang Z; Huang Y; Newman K; Gu J; Zhang X; Wu H; Zhao M; Xianyu Z; Liu X
Clin Cancer Res; 2009 Aug; 15(16):5154-60. PubMed ID: 19671855
[TBL] [Abstract][Full Text] [Related]
34. Coxsackievirus B3 is an oncolytic virus with immunostimulatory properties that is active against lung adenocarcinoma.
Miyamoto S; Inoue H; Nakamura T; Yamada M; Sakamoto C; Urata Y; Okazaki T; Marumoto T; Takahashi A; Takayama K; Nakanishi Y; Shimizu H; Tani K
Cancer Res; 2012 May; 72(10):2609-21. PubMed ID: 22461509
[TBL] [Abstract][Full Text] [Related]
35. Tumor suppression by apoptotic and anti-angiogenic effects of mortalin-targeting adeno-oncolytic virus.
Yoo JY; Ryu J; Gao R; Yaguchi T; Kaul SC; Wadhwa R; Yun CO
J Gene Med; 2010 Jul; 12(7):586-95. PubMed ID: 20603860
[TBL] [Abstract][Full Text] [Related]
36. Oncolytic Newcastle disease virus delivered by Mesenchymal stem cells-engineered system enhances the therapeutic effects altering tumor microenvironment.
Keshavarz M; Ebrahimzadeh MS; Miri SM; Dianat-Moghadam H; Ghorbanhosseini SS; Mohebbi SR; Keyvani H; Ghaemi A
Virol J; 2020 May; 17(1):64. PubMed ID: 32370750
[TBL] [Abstract][Full Text] [Related]
37. Oncolytic activity of avian influenza virus in human pancreatic ductal adenocarcinoma cell lines.
Kasloff SB; Pizzuto MS; Silic-Benussi M; Pavone S; Ciminale V; Capua I
J Virol; 2014 Aug; 88(16):9321-34. PubMed ID: 24899201
[TBL] [Abstract][Full Text] [Related]
38. Seneca Valley virus, a systemically deliverable oncolytic picornavirus, and the treatment of neuroendocrine cancers.
Reddy PS; Burroughs KD; Hales LM; Ganesh S; Jones BH; Idamakanti N; Hay C; Li SS; Skele KL; Vasko AJ; Yang J; Watkins DN; Rudin CM; Hallenbeck PL
J Natl Cancer Inst; 2007 Nov; 99(21):1623-33. PubMed ID: 17971529
[TBL] [Abstract][Full Text] [Related]
39. Naturally Existing Oncolytic Virus M1 Is Nonpathogenic for the Nonhuman Primates After Multiple Rounds of Repeated Intravenous Injections.
Zhang H; Lin Y; Li K; Liang J; Xiao X; Cai J; Tan Y; Xing F; Mai J; Li Y; Chen W; Sheng L; Gu J; Zhu W; Yin W; Qiu P; Su X; Lu B; Tian X; Liu J; Lu W; Dou Y; Huang Y; Hu B; Kang Z; Gao G; Mao Z; Cheng SY; Lu L; Bai XT; Gong S; Yan G; Hu J
Hum Gene Ther; 2016 Sep; 27(9):700-11. PubMed ID: 27296553
[TBL] [Abstract][Full Text] [Related]
40. Oncolytic virotherapy for oral squamous cell carcinoma using replication-competent viruses.
Saito K; Shirasawa H; Isegawa N; Shiiba M; Uzawa K; Tanzawa H
Oral Oncol; 2009 Dec; 45(12):1021-7. PubMed ID: 19833547
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
